Stockholders' Equity (Details)
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
|
|
|
|
|
|
|
Jan. 22, 2020
USD ($)
$ / shares
shares
|
Dec. 09, 2019
$ / shares
shares
|
Nov. 30, 2019
USD ($)
|
Aug. 20, 2019
investor
shares
|
Aug. 17, 2019
shares
|
Aug. 01, 2019
USD ($)
subsidiary
$ / shares
shares
|
Jun. 18, 2019
shares
|
May 13, 2019
$ / shares
shares
|
Dec. 24, 2018
USD ($)
shares
|
Dec. 31, 2019
USD ($)
shares
|
Nov. 30, 2019
USD ($)
shares
|
Sep. 30, 2018
USD ($)
$ / shares
shares
|
Jan. 31, 2020
USD ($)
shares
|
Oct. 31, 2019
USD ($)
shares
|
Jul. 31, 2019
USD ($)
shares
|
Jan. 31, 2019
USD ($)
shares
|
Jan. 31, 2020
USD ($)
shares
|
Jan. 31, 2019
USD ($)
shares
|
Dec. 30, 2019
shares
|
Jun. 28, 2019
shares
|
Jun. 07, 2019
shares
|
Jun. 03, 2019
shares
|
Apr. 30, 2019
shares
|
Dec. 13, 2018
shares
|
Mar. 13, 2012
shares
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
1,000,000
|
|
|
|
|
|
1,000,000
|
|
|
Preferred stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
0
|
|
|
Preferred stock outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
0
|
|
|
Common stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
40,000,000
|
|
|
|
40,000,000
|
|
|
|
|
|
40,000,000
|
|
|
Common stock issued for stock options exercised for cash | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 530,668
|
$ 192,522
|
$ 45,190
|
$ 50,041
|
$ 768,381
|
$ 110,143
|
|
|
|
|
|
|
|
Proceeds from issuance of stock issued in equity raise | $ |
$ 17,267,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 16,044,879
|
$ 0
|
|
|
|
|
|
|
|
Common stock issued in equity raise (in dollars per share) | $ / shares |
$ 7.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds of equity issuance | $ |
$ 16,044,879
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years
|
|
|
|
|
|
|
|
|
Restricted stock issued, fair value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
Number of investors electing cashless exercises | investor |
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
21,727,075
|
|
|
|
21,727,075
|
|
|
|
|
|
18,665,551
|
|
|
Compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 805,405
|
|
|
|
$ 1,721,293
|
|
|
|
|
|
|
|
|
Unrecognized compensation costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 930,000
|
|
|
|
$ 930,000
|
|
|
|
|
|
|
|
|
Over-Allotment Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of stock, number of share issued in transaction |
315,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
Restricted shares granted, value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 122,250
|
|
|
|
|
|
|
|
|
Equity Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares granted (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
177,046
|
|
|
|
177,046
|
|
|
|
|
|
|
|
|
Number of shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,100,000
|
|
|
|
|
500,000
|
3,500,000
|
Common stock, shares remaining for future issuance (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
109,352
|
|
|
|
109,352
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cashless stock options exercised (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
8,352
|
80,313
|
101,894
|
55,871
|
190,559
|
86,635
|
|
|
|
|
|
|
|
Common stock issued for stock options exercised for cash (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
121,407
|
90,950
|
21,876
|
22,985
|
234,233
|
49,792
|
|
|
|
|
|
|
|
Common stock issued for stock options exercised for cash | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 121
|
|
|
$ 23
|
$ 234
|
$ 49
|
|
|
|
|
|
|
|
Common stock issued for services (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for services | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 177,500
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
144,803
|
|
|
|
|
|
|
|
|
Common stock issued in equity raise (in shares) |
2,415,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cashless warrant exercise (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
57,526
|
19,403
|
35,921
|
76,929
|
35,921
|
|
|
|
|
|
|
|
Cashless exercise of warrants (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
121,070
|
43,860
|
|
|
|
|
|
|
|
|
|
|
Restricted stock issued, fair value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 40
|
|
|
|
$ 144
|
|
|
|
|
|
|
|
|
Common Stock | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,000,000
|
|
|
|
|
|
Common Stock | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000,000
|
|
|
|
|
|
Preferred Stock | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
Preferred Stock | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
|
|
|
Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unvested shares of restricted common stock outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
226,922
|
|
|
|
226,922
|
|
|
|
|
|
|
|
|
Total unrecognized compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,285,524
|
|
|
|
$ 1,285,524
|
|
|
|
|
|
|
|
|
Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
30,131
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock issued, fair value | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 122,332
|
|
|
|
|
|
|
|
|
|
|
|
Former Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,806
|
|
|
|
Former Director | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,930
|
|
|
|
Chief Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,597
|
|
|
|
|
Chief Financial Officer | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued in equity raise (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds of equity issuance | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 103,350
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cashless warrant exercise (in shares) |
|
|
|
8,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor 1 | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrants (in shares) |
|
|
|
18,818
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cashless warrant exercise (in shares) |
|
|
|
42,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor 2 | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrants (in shares) |
|
|
|
88,710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cashless warrant exercise (in shares) |
|
|
|
|
6,271
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor | Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrants (in shares) |
|
|
|
|
13,542
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 188,031
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares granted (in shares) |
|
|
|
|
|
|
|
|
24,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock vesting period |
|
|
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock | Investor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares vested (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
5,000
|
|
|
|
5,000
|
|
|
|
|
|
|
|
|
Restricted Stock | Andrew Kaplan Current Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (in shares) |
|
|
|
|
|
|
5,131
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted (in shares) |
|
|
|
|
|
|
5,131
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock | Two former directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (in shares) |
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted (in shares) |
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock | Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted, value | $ |
|
|
|
|
|
|
|
|
$ 126,320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock | Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total unrecognized compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 180,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted (in shares) |
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock price on date of grant (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 7.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting percentage of award |
|
|
66.67%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization | $ |
|
|
$ 108,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-qualified stock options to certain former directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (in shares) |
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted (in shares) |
|
|
|
|
|
|
|
30,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of stock options | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 33,600
|
|
|
|
|
|
|
|
|
|
|
Terms of share-based payment award |
|
|
|
|
|
|
|
five years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based payment award exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 4.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Payment Arrangement, Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted (in shares) |
|
61,000
|
|
|
|
59,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted (in shares) |
|
61,000
|
|
|
|
59,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of options for services performed (in dollars per share) | $ / shares |
|
$ 6.92
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of stock options | $ |
|
|
|
|
|
$ 83,000
|
|
|
|
|
|
|
$ 116,000
|
|
|
|
$ 116,000
|
|
|
|
|
|
|
|
|
Options granted, number of employees | subsidiary |
|
|
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognition period of stock options (in months) |
|
|
|
|
|
36 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price of options (in dollars per share) | $ / shares |
|
|
|
|
|
$ 3.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of RSUs | $ |
|
|
|
|
|
|
|
|
|
$ 826,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) | Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted (in shares) |
|
|
|
|
|
|
|
|
|
100,000
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of RSUs | $ |
|
|
314,500
|
|
|
|
|
|
|
|
$ 314,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) | Chief Accounting Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted (in shares) |
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) | Employees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted shares granted (in shares) |
|
|
|
|
|
|
|
|
|
|
17,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of RSUs | $ |
|
|
$ 108,500
|
|
|
|
|
|
|
|
$ 108,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|